Table 1 Patients demographics and clinical variables
No pulmonary clinic visit in prior 3 years (n = 122) | Pulmonary clinic visit in prior 3 years (n = 78) | p value | |
|---|---|---|---|
Age in years (mean ± SD) | 70.5 ± 10.8 | 70.4 ± 10.9 | 0.9 |
Age ≥ 65-year-old, n(%) | 82 (65.5) | 54 (69.2) | 0.7 |
Men, n (%) | 56 (45.9) | 44 (56.4) | 0.2 |
Smoking status, n (%) | |||
Never | 6 (4.9) | 10 (12.8) | 0.005 |
Former | 57 (46.7) | 20 (25.6) | |
Current | 56 (45.9) | 46 (58.9) | |
PFT ever done, n (%) | 70 (57.3) | 77 (98.7) | < 0.001 |
Obstructive pattern confirmed on PFT (%) | 42 (60.0) | 66 (85.7) | < 0.001 |
FEV1/FVC (mean ± SD) | 69.4 ± 11.3 | 65.1 ± 14.6 | 0.07 |
Airflow limitation by FEV1 in those with obstructive pattern, n (%) | |||
GOLD 1 (mild) | 8 (19.0) | 7 (10.6) | 0.02 |
GOLD2 (moderate) | 28 (66.6) | 30 (45.5) | |
GOLD 3 (severe) | 5 (11.9) | 24 (36.4) | |
GOLD 4 (very severe) | 1 (2.4) | 5 (7.5) | |
PCV13, n (%) | 71/87 (81.6) | 57/59 (96.6) | 0.009 |
PPSV23, n (%) | 100/118 (84.7) | 74/78 (94.8) | 0.03 |
Influenza vaccination 2017, n (%) | 77(63.1) | 63(80.8) | 0.008 |
Influenza vaccination 2018, n (%) | 76(62.8) | 62(80.5) | 0.008 |
Influenza vaccination 2019, n (%) | 60 (52.2) | 53(70.7) | 0.01 |
COPD hospitalization in prior 12 months, n (%) | 3 (2.4) | 16 (20.5) | < 0.001 |
Death in 2017–2019, n (%) | 8 (6.5) | 5 (6.4) | 1.0 |